Cargando…
Disease X ver1.0: COVID-19
The SARS-Cov2 has presented the world with a novel pandemic challenge requiring a rapid response. This article provides a May 2020 snapshot from Professor Paul Young, who is part of a group working with urgency on Australia’s leading COVID-19 candidate vaccine.
Autor principal: | Young, Paul R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CSIRO Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263844/ http://dx.doi.org/10.1071/MA20028 |
Ejemplares similares
-
Wine Yeasts 1.0
por: Sipiczki, Matthias
Publicado: (2021) -
SHARED FILE SYSTEM (SFS) Vademecum, Vers. 1.0
por: Hern\`andez, J J
Publicado: (1992) -
Pathogenesis of Pregnancy-Related Complications 1.0 and 2.0
por: Hromadnikova, Ilona
Publicado: (2022) -
Phytoplankton–Bacteria Interactions 1.0
por: Petrou, Katherina
Publicado: (2023) -
From Rheumatology 1.0 to Rheumatology 4.0 and beyond: the contributions of Big Data to the field of rheumatology
por: Bragazzi, Nicola Luigi, et al.
Publicado: (2019)